annual total liabilities:
$44.97B+$14.10B(+45.66%)Summary
- As of today (April 14, 2025), NVO annual total liabilities is $44.97 billion, with the most recent change of +$14.10 billion (+45.66%) on December 31, 2024.
- During the last 3 years, NVO annual total liabilities has risen by +$26.13 billion (+138.67%).
- NVO annual total liabilities is now at all-time high.
Performance
NVO Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$44.97B+$3.49B(+8.41%)Summary
- As of today (April 14, 2025), NVO quarterly total liabilities is $44.97 billion, with the most recent change of +$3.49 billion (+8.41%) on December 31, 2024.
- Over the past year, NVO quarterly total liabilities has stayed the same.
- NVO quarterly total liabilities is now at all-time high.
Performance
NVO quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NVO Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.7% | 0.0% |
| 3 y3 years | +138.7% | +138.7% |
| 5 y5 years | +341.0% | +341.0% |
NVO Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +138.7% | at high | +129.5% |
| 5 y | 5-year | at high | +341.0% | at high | +323.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Novo Nordisk A/S Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $44.97B(+45.7%) | $44.97B(+8.4%) |
| Sep 2024 | - | $41.48B(+12.5%) |
| Jun 2024 | - | $36.87B(+27.4%) |
| Mar 2024 | - | $28.93B(-6.3%) |
| Dec 2023 | $30.87B(+35.9%) | $30.87B(+5.2%) |
| Sep 2023 | - | $29.33B(+5.6%) |
| Jun 2023 | - | $27.77B(+11.5%) |
| Mar 2023 | - | $24.91B(+9.7%) |
| Dec 2022 | $22.71B(+20.5%) | $22.71B(+3.4%) |
| Sep 2022 | - | $21.96B(+8.3%) |
| Jun 2022 | - | $20.28B(+3.5%) |
| Mar 2022 | - | $19.60B(+4.0%) |
| Dec 2021 | $18.84B(+39.7%) | $18.84B(+11.8%) |
| Sep 2021 | - | $16.84B(+13.8%) |
| Jun 2021 | - | $14.81B(+13.3%) |
| Mar 2021 | - | $13.07B(-3.1%) |
| Dec 2020 | $13.49B(+32.3%) | $13.49B(+6.4%) |
| Sep 2020 | - | $12.67B(+10.4%) |
| Jun 2020 | - | $11.48B(+8.1%) |
| Mar 2020 | - | $10.61B(+4.1%) |
| Dec 2019 | $10.20B(+13.0%) | $10.20B(-3.3%) |
| Sep 2019 | - | $10.54B(+6.8%) |
| Jun 2019 | - | $9.88B(+4.6%) |
| Mar 2019 | - | $9.44B(+4.6%) |
| Dec 2018 | $9.03B(+6.6%) | $9.03B(+6.7%) |
| Sep 2018 | - | $8.46B(+0.7%) |
| Jun 2018 | - | $8.40B(+3.1%) |
| Mar 2018 | - | $8.15B(-3.7%) |
| Dec 2017 | $8.47B(+13.9%) | $8.47B(+5.0%) |
| Sep 2017 | - | $8.06B(+6.1%) |
| Jun 2017 | - | $7.60B(-1.9%) |
| Mar 2017 | - | $7.74B(+4.2%) |
| Dec 2016 | $7.43B(+13.2%) | $7.43B(+7.3%) |
| Sep 2016 | - | $6.92B(+1.4%) |
| Jun 2016 | - | $6.83B(-0.3%) |
| Mar 2016 | - | $6.85B(+4.4%) |
| Dec 2015 | $6.57B(+9.4%) | $6.57B(+3.4%) |
| Sep 2015 | - | $6.35B(+0.1%) |
| Jun 2015 | - | $6.34B(-3.5%) |
| Mar 2015 | - | $6.57B(+9.5%) |
| Dec 2014 | $6.00B(+16.8%) | $6.00B(+5.7%) |
| Sep 2014 | - | $5.68B(+14.9%) |
| Jun 2014 | - | $4.94B(-9.5%) |
| Mar 2014 | - | $5.46B(+6.3%) |
| Dec 2013 | $5.14B(+15.8%) | $5.14B(-2.1%) |
| Sep 2013 | - | $5.25B(+3.8%) |
| Jun 2013 | - | $5.06B(+2.7%) |
| Mar 2013 | - | $4.92B(+10.9%) |
| Dec 2012 | $4.44B(-6.5%) | $4.44B(-17.2%) |
| Sep 2012 | - | $5.36B(+8.1%) |
| Jun 2012 | - | $4.96B(-3.9%) |
| Mar 2012 | - | $5.16B(+8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $4.75B(+8.9%) | $4.75B(-2.1%) |
| Sep 2011 | - | $4.85B(+1.8%) |
| Jun 2011 | - | $4.77B(+3.9%) |
| Mar 2011 | - | $4.59B(+5.2%) |
| Dec 2010 | $4.36B(+19.2%) | $4.36B(+4.1%) |
| Sep 2010 | - | $4.19B(+8.9%) |
| Jun 2010 | - | $3.84B(-0.2%) |
| Mar 2010 | - | $3.85B(+5.4%) |
| Dec 2009 | $3.66B(+10.3%) | $3.66B(+4.9%) |
| Sep 2009 | - | $3.49B(+7.8%) |
| Jun 2009 | - | $3.23B(-3.5%) |
| Mar 2009 | - | $3.35B(+1.1%) |
| Dec 2008 | $3.32B(+8.9%) | $3.32B(+4.5%) |
| Sep 2008 | - | $3.17B(-2.6%) |
| Jun 2008 | - | $3.26B(-5.1%) |
| Mar 2008 | - | $3.44B(+12.8%) |
| Dec 2007 | $3.05B(+18.2%) | $3.05B(+4.3%) |
| Sep 2007 | - | $2.92B(+8.2%) |
| Jun 2007 | - | $2.70B(-0.1%) |
| Mar 2007 | - | $2.70B(+4.8%) |
| Dec 2006 | $2.58B(+13.6%) | $2.58B(-2.0%) |
| Sep 2006 | - | $2.63B(+7.8%) |
| Jun 2006 | - | $2.44B(+5.3%) |
| Mar 2006 | - | $2.31B(+2.0%) |
| Dec 2005 | $2.27B(+13.2%) | $2.27B(+3.7%) |
| Sep 2005 | - | $2.19B(+11.6%) |
| Jun 2005 | - | $1.96B(+4.5%) |
| Mar 2005 | - | $1.88B(-6.4%) |
| Dec 2004 | $2.00B(+28.9%) | $2.00B(+20.9%) |
| Sep 2004 | - | $1.66B(+8.5%) |
| Jun 2004 | - | $1.53B(-5.1%) |
| Mar 2004 | - | $1.61B(+3.5%) |
| Dec 2003 | $1.56B(+28.7%) | $1.56B(+28.7%) |
| Dec 2002 | $1.21B(+16.5%) | $1.21B(+16.5%) |
| Dec 2001 | $1.04B(-6.0%) | $1.04B(-6.0%) |
| Dec 2000 | $1.10B(+3.4%) | $1.10B(+3.4%) |
| Dec 1999 | $1.07B(-26.8%) | $1.07B(-26.8%) |
| Dec 1998 | $1.46B(+32.3%) | $1.46B(+32.3%) |
| Dec 1997 | $1.10B(+4.6%) | $1.10B(+4.6%) |
| Dec 1996 | $1.05B(+2.1%) | $1.05B(+2.1%) |
| Dec 1995 | $1.03B(-21.5%) | $1.03B(-21.5%) |
| Dec 1994 | $1.31B(+22.2%) | $1.31B(+22.2%) |
| Dec 1993 | $1.08B(+8.2%) | $1.08B(+8.2%) |
| Dec 1992 | $994.29M(+1.9%) | $994.29M(+1.9%) |
| Dec 1991 | $975.82M(+3.1%) | $975.82M(+3.1%) |
| Dec 1990 | $946.22M(+15.9%) | $946.22M(+15.9%) |
| Dec 1989 | $816.44M(+51.8%) | $816.44M(+51.8%) |
| Dec 1988 | $537.70M(+5.8%) | $537.70M(+5.8%) |
| Dec 1987 | $508.19M(-8.4%) | $508.19M(-8.4%) |
| Dec 1986 | $554.52M(+103.3%) | $554.52M(+103.3%) |
| Dec 1985 | $272.73M(+21.2%) | $272.73M(+21.2%) |
| Dec 1984 | $225.10M | $225.10M |
FAQ
- What is Novo Nordisk A/S annual total liabilities?
- What is the all time high annual total liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total liabilities year-on-year change?
What is Novo Nordisk A/S annual total liabilities?
The current annual total liabilities of NVO is $44.97B
What is the all time high annual total liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total liabilities is $44.97B
What is Novo Nordisk A/S annual total liabilities year-on-year change?
Over the past year, NVO annual total liabilities has changed by +$14.10B (+45.66%)
What is Novo Nordisk A/S quarterly total liabilities?
The current quarterly total liabilities of NVO is $44.97B
What is the all time high quarterly total liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total liabilities is $44.97B
What is Novo Nordisk A/S quarterly total liabilities year-on-year change?
Over the past year, NVO quarterly total liabilities has changed by $0.00 (0.00%)